Pharmacell SRL
The score of Pharmacell shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -16 % Total assets +5 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacell's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Jun 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 19 Jul 2024
- Year ended 31 Dec 2022filed on 24 Aug 2023
- Year ended 31 Dec 2021filed on 12 Aug 2022
Pharmacell's financial analysis
- Solvency31.2%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacell
Pharmacell's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0738.956.985
- VAT number
- BE0738956985
- Peppol
- Registered · 0208:0738956985 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Dec 2019
- Registered office
- 9790 Wortegem-Petegem
- Latest accounts
- 2025 · filed on 26 Jun 2026
- Activity
- Activities of holding companies (NACE 64210)
Pharmacell (SRL) has been based in Wortegem-Petegem since 2019, active in: activities of holding companies. For 2025, it reports a net profit of 223,035 € and equity of 494,200 €; its revenue is not published. Its solvency stands at 31.2%, below the median of its sector (55.6%).
Companies similar to Pharmacell
Companies in the same business, of comparable size and area, outside its group.
- Plastipharm Activities of holding companies Knokke-Heist · balance sheet €1.58m
- Debruma Activities of holding companies Pittem · balance sheet €1.58m
- Martens Management Activities of holding companies Genk · balance sheet €1.58m
- MVH Invest Activities of holding companies Herenthout · balance sheet €1.52m
- FC2 Activities of holding companies Blegny · balance sheet €1.58m
- Tausy Activities of holding companies Bruges · balance sheet €1.59m
- Lomas Activities of holding companies Koksijde · balance sheet €1.58m
- Equit Finance & Management Activities of holding companies Uccle · balance sheet €1.59m
Frequently asked questions about Pharmacell
What is the revenue of Pharmacell?
Pharmacell files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmacell?
In Belgium, the VAT number is the company number prefixed with BE: BE0738956985 for Pharmacell, if the company is VAT-registered. Its company number (CBE) is 0738.956.985.
Where is the registered office of Pharmacell?
According to the CBE register, the registered office of Pharmacell is in 9790 Wortegem-Petegem.
What is the equity of Pharmacell?
At the close of the 2025 financial year, the equity of Pharmacell amounts to 494,200 €, a solvency of 31.2% of total assets.
Who manages Pharmacell?
The register lists 1 active mandates at Pharmacell. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacell
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →